142 related articles for article (PubMed ID: 20947547)
1. Major lupus organ involvement: severe lupus nephritis.
Avihingsanon Y; Hirankarn N
Lupus; 2010 Oct; 19(12):1391-8. PubMed ID: 20947547
[TBL] [Abstract][Full Text] [Related]
2. Natural history and treatment of lupus nephritis.
Austin HA; Balow JE
Semin Nephrol; 1999 Jan; 19(1):2-11. PubMed ID: 9952276
[TBL] [Abstract][Full Text] [Related]
3. Treatment for lupus nephritis: a revisit.
Lai KN; Tang SC; Mok CC
Nephrology (Carlton); 2005 Apr; 10(2):180-8. PubMed ID: 15877679
[TBL] [Abstract][Full Text] [Related]
4. Lupus nephritis.
Sauter M; Anders HJ
Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
6. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
8. Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions.
Ortega LM; Schultz DR; Lenz O; Pardo V; Contreras GN
Lupus; 2010 Apr; 19(5):557-74. PubMed ID: 20089610
[TBL] [Abstract][Full Text] [Related]
9. The nephropathy of systemic lupus erythematosus.
Balow JE
In Vivo; 1988; 2(1):111-4. PubMed ID: 2979809
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and management of refractory lupus nephritis.
Pons-Estel GJ; Serrano R; Plasín MA; Espinosa G; Cervera R
Autoimmun Rev; 2011 Sep; 10(11):655-63. PubMed ID: 21565286
[TBL] [Abstract][Full Text] [Related]
11. [Lupus nephritis in Senegal: study of 42 cases].
Dia D; Ka EF; Cissé M; Pouye A; Niang NM; Kane A; Dieng MT; Niang A; Ka MM; Diouf B; Ndiaye B; Moreira-Diop T
Dakar Med; 2007; 52(1):23-6. PubMed ID: 19102087
[TBL] [Abstract][Full Text] [Related]
12. Beyond immunosuppression - challenges in the clinical management of lupus nephritis.
Masood S; Jayne D; Karim Y
Lupus; 2009 Feb; 18(2):106-15. PubMed ID: 19151111
[TBL] [Abstract][Full Text] [Related]
13. Studies of immunosuppressive drugs in the treatment of lupus nephritis.
Klippel JH; Austin HA; Balow JE; leRiche NG; Steinberg AD; Plotz PH; Decker JL
Rheum Dis Clin North Am; 1987 Apr; 13(1):47-56. PubMed ID: 3306824
[TBL] [Abstract][Full Text] [Related]
14. [Lupus nephritis: retrospective analysis of the course of the disease].
Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
[TBL] [Abstract][Full Text] [Related]
15. The benefit of early treatment with immunosuppressive agents in lupus nephritis.
Esdaile JM; Joseph L; MacKenzie T; Kashgarian M; Hayslett JP
J Rheumatol; 1994 Nov; 21(11):2046-51. PubMed ID: 7869308
[TBL] [Abstract][Full Text] [Related]
16. Lupus nephritis and end-stage kidney disease.
Maroz N; Segal MS
Am J Med Sci; 2013 Oct; 346(4):319-23. PubMed ID: 23370533
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence.
Bruce IN; Gladman DD; Urowitz MB
Arthritis Care Res; 2000 Dec; 13(6):406-8. PubMed ID: 14635317
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of patients with biopsy-proven lupus nephritis in NUH.
Gan HC; Hyoon K; Fong KY
Singapore Med J; 2002 Dec; 43(12):614-6. PubMed ID: 12693764
[TBL] [Abstract][Full Text] [Related]
19. Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival.
Sisó A; Ramos-Casals M; Bové A; Brito-Zerón P; Soria N; Muñoz S; Testi A; Plaza J; Sentís J; Coca A
Lupus; 2008 Apr; 17(4):281-8. PubMed ID: 18413408
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of diffuse proliferative lupus nephritis.
Lim CS; Chin HJ; Jung YC; Kim YS; Ahn C; Han JS; Kim S; Lee JS
Clin Nephrol; 1999 Sep; 52(3):139-47. PubMed ID: 10499308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
